Out of the ASX300. Not a surprise. But just another sterling achievement from our management team.
All of us on here should be emailing the company voicing our discontent.
Anyone here who can say they are just happy to be patient is delusional. This isnt about wanting quick gains. Its about the fact we have an incompetent management team who may be the reason a drug we know works and with a huge addressable market, never makes it.
The next nail is a heavily dilutionary capital raising at a ridiculous share price.
Be proactive and hold management to account.
Ann: S&P DJI Announces March 2022 Quarterly Rebalance, page-2
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.005(2.04%) |
Mkt cap ! $83.98M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.5¢ | 24.0¢ | $202.2K | 814.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 181098 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 118621 | 5 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |